反応式
CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.Cl.[O:26]=[C:27]1[N:36]([CH:37]([CH3:41])[C:38]([OH:40])=O)[CH:35]=[CH:34][C:33]2[N:32]=[CH:31][CH:30]=[CH:29][C:28]1=2.[F:42][C:43]1[C:44]([NH:55][NH2:56])=[N:45][CH:46]=[C:47]([C:49]2[CH:50]=[N:51][N:52]([CH3:54])[CH:53]=2)[CH:48]=1.CCN(C(C)C)C(C)C>C(#N)C>[F:42][C:43]1[C:44]([NH:55][NH:56][C:38](=[O:40])[CH:37]([N:36]2[CH:35]=[CH:34][C:33]3[N:32]=[CH:31][CH:30]=[CH:29][C:28]=3[C:27]2=[O:26])[CH3:41])=[N:45][CH:46]=[C:47]([C:49]2[CH:50]=[N:51][N:52]([CH3:54])[CH:53]=2)[CH:48]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
HATU (1053 mg, 2.7 mmol), 2-(5-oxo-1,6-naphthyridin-6(5H)-yl)propanoic acid hydrochloride (470 mg, 1.8 mmol) and 1-(3-fluoro-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-yl)hydrazine (421 mg, 2 mmol) (step 1 of General Method K) were taken up in 6 mL of acetonitrile. DIPEA (967 μl, 5.5 mmol) was added and the reaction was stirred for 30 minutes, until reaction was complete. The crude material was concentrated and then purified via MPLC with a gradient 100% DCM to 90% DCM/10% MeOH/1% NH4OH) to yield N′-(3-fluoro-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-yl)-2-(5-oxo-1,6-naphthyridin-6(5H)-yl)propanehydrazide (500 mg, 67% yield).
後処理
- concentrationThe crude material was concentrated
- custompurified via MPLC with a gradient 100% DCM to 90% DCM/10% MeOH/1% NH4OH)
出典と根拠
- ORDレコード
- ord-ff746182ae2647459d84117ec248d280
- 出典データセット
- uspto-grants-2012_06
- 特許番号
- US08198448B2
関連ノート
読み込み中…